Delivery Order SPE2DB20D2104-SPE2DB23FU28W
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,141.59 Firm Fixed Price delivery order contract is for the supply of EXFORGE 10-160 MG TABLET 30S, a cardiovascular medication. The contract has an ultimate completion date of December 13, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $4,166.30, is a Firm Fixed Price Delivery Order contract for the supply of EXFORGE 10-320 MG TABLET 30S medication. The contract has an ultimate completion date of February 16, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order valued at $1,682.40 for 4566529191 EXFORGE 5-320 MG TABLET 30S. The contract has a firm fixed price and an ultimate completion date of November 25, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,813.31 Firm Fixed Price Delivery Order contract is for the supply of EXFORGE 10-320 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of May 12, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,331.48 delivery order contract is for the supply of EXFORGE 10-320 MG TABLET 30S, a cardiovascular medication. The award has a firm fixed price pricing type and a completion date of June 14, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,021.83 firm fixed-price delivery order is for EXFORGE 10-320 MG TABLET 30S, a pharmaceutical product. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $8,037.96 firm fixed-price delivery order covers the supply of 4555938848 units of the pharmaceutical product EXFORGE 5-160 MG TABLET 30S. The award has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,001.00 firm fixed-price delivery order is for the supply of EXFORGE 10-160 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of June 13, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award, SPE2DB20D3101/SPE2DB25FRBF9, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,624.29 firm fixed-price delivery order is for the supply of EXFORGE 5-160 MG TABLET 30S, a cardiovascular medication. The contract has an ultimate completion date of February 10, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a Delivery Order valued at $8,253.93, is for the delivery of EXFORGE 10-320 MG TABLET 30S, a pharmaceutical product. The contract has a completion date of January 25, 2024 and is a Firm Fixed Price contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FU28WDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company and subsidiary of Cencora, Inc. The $7,542.07 firm fixed-price delivery order is for the supply of EXFORGE 5-160 MG TABLET 30S, a cardiovascular medication. The award has an ultimate completion date of July 7, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries. The contract award is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen's extensive federal contract history and supply chain capabilities position the company as a critical vendor for the DLA and other government agencies in meeting their pharmaceutical and medical supply needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.5k | 7/6/23 |